While these increases typically resolved or stabilized, they represent a unique variable for researchers to monitor
Micronutrients, Electrolytes, and GI Tolerability Micronutrient support addresses the arithmetic of eating far less food
TRIUMPH (obesity-focused, 4 core registrational trials) has TRIUMPH-1 and TRIUMPH-4 complete, with TRIUMPH-2 (obesity+diabetes) and TRIUMPH-3 (obesity+cardiovascular disease) expected later in 2026
The goal is to feel better in your body while protecting your health
Dysbiosis, characterized by altered bacterial composition and abundance, has been implicated in the pathogenesis of various diseases, including inflammatory conditions, cancers, cardiovascular diseases, and metabolic disorders like diabetes and obesity (Thursby and Juge, 2017)
Moreover, DON treatment sensitizes pancreatic tumors to immune checkpoint blockade therapy, resulting in tumor growth inhibition and prolonged survival (Sharma et al., 2020)